-
AI may help assess brain injury patients
biospectrumasia
September 06, 2018
Studies have shown that patients with traumatic brain injury have a higher likelihood of recovery than those with non-traumatic brain injury, and young patients are more likely to have a favourable outcome than older ones.
-
Doctors worry Shingrix side effects will put patients off their second dose
fiercevaccines
July 23, 2018
The CDC has urged people 50 and older to get GlaxoSmithKline's new shingles vaccine to protect against a notoriously painful condition. But amid the company's important launch, some doctors are worried patients won't return for their second dose if they e
-
Want to help patients? Get rid of drug rebates, HHS chief says
fiercepharma
June 14, 2018
Drug rebates and list prices have been on a race to the top, and patients have paid the price.
-
CENTOGENE Announces Agreement with Aldeyra Therapeutics for the Advancement of Novel Therapeutics for Patients with Sjögren-Larsson Syndrome
firstwordpharma
May 30, 2018
ROSTOCK, Germany--(BUSINESS WIRE)-- CENTOGENE, the worldwide leader in elucidating rare disease genetics for patients, clinicians and pharmaceutical partners, today announced that it has entered into an agreement with Aldeyra Therapeutics Inc.,
-
TXA may benefit stroke patients
europeanpharmaceuticalreview
May 22, 2018
Patients with stroke caused by bleeding on the brain may benefit from receiving a drug currently used to treat blood loss from major trauma and bleeding after childbirth…
-
New cancer immunotherapy drugs rapidly reach patients after approval
europeanpharmaceuticalreview
May 15, 2018
The majority of patients eligible for cancer immunotherapy drugs known as checkpoint inhibitors received treatment within a few months of FDA approval, according to a new Yale-led study.
-
myAirvo significantly benefits COPD Patients
biospectrumasia
April 23, 2018
The trial is the largest study of this treatment length to have been conducted in a home environment and was led by researchers Line Storgaard and Dr Ulla Weinreich.
-
Ofev Study Results Released of Fibrotic Progression in Patients with IPF
americanpharmaceuticacreview
November 13, 2017
Boehringer Ingelheim announced results from a descriptive Phase IIIb lung imaging study providing evidence for the first time that Ofev (nintedanib) slowed the fibrotic process versus placebo in people with idiopathic pulmonary fibrosis (IPF).
-
Reference pricing encourages patients to choose cheaper prescription drugs
worldpharmanews
August 23, 2017
As prescription drug spending continues to rise in the United States, along with prices for new and well-established drugs,
-
mindBEAGLE: The first EEG-based BCI System Ever for Communication with Complete Locked-in Patients
en-cphi.cn
June 13, 2017
Frontiers in Neuroscience recently published an article presenting mindBEAGLE as the very first and only EEG-based Brain-Computer Interface (BCI) that enables communication with patients who suffer from locked-in syndrome (LIS)...